Copyright
©The Author(s) 2004.
World J Gastroenterol. May 1, 2004; 10(9): 1281-1285
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1281
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1281
Table 3 Patient characteristics and radionuclide imaging
| Group | Cases | Tumor size (cm) | 99mTc-MIBI SPECT | Immunohistochemistry | RT-PCR | ||||||
| L/Ne | L/Nd | L/Nwr (%) | Pgp | MRP | LRP | mdr1 | MRP | LRP | |||
| I | 68 | 2.5-15 | 2.09 ± 0.67 | 1.25 ± 0.42 | 54.94 ± 10.23 | 68 (+) | 4 (+) | 3 (+) | 0.38 ± 0.16 | 0.04 ± 0.02 | 0.02 ± 0.01 |
| II | 10 | 1.5-7 | 1.98 ± 0.56 | 2.78 ± 0.53 | 3.07 ± 0.57 | 10 (-) | 3 (+) | 1 (+) | 0 | 0.06 ± 0.03 | 0.03 |
- Citation: Wang H, Chen XP, Qiu FZ. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(9): 1281-1285
- URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1281.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1281